Sentrx Business Development Team Expands
Sentrx continues to add to its Business Development staff by hiring three new outstanding solution oriented individuals.
Little Falls, NJ (I-Newswire) December 5, 2012 - Sentrx, the industry-leader in global pharmacovigilance outsourcing, is pleased to announce the hiring of three professionals to enhance its business development team.
• Craig Hatton, Director, Commercial Solutions Eastern North America, previously worked in business development and sales at Biomedical Systems, Delta Pharma, Liquent Inc. and Thomson Scientific.
• Suzette Sutton, Business Development Technical Engineer, previously employed by BSI Group – Entropy, IntelliSoft Group, Cornell/Columbia New York Presbyterian, and Fidelity Investments.
• Janice Scheider, Business Development Channel Manager, previous work experience includes various positions at Foresight Group International, and Kemper Insurance Companies.
“Adding talent to our Business Development team will pay tremendous dividends to our prospective clients, our current clients and our company” says Michael O’Gorman, CEO of Sentrx. “Craig, Suzette and Janice bring the experience and personality necessary to build strong relationships with our clients, and will play integral roles in developing valuable solutions for them,” adds O’Gorman. “Our company philosophy begins with a strong client-centric foundation, and the addition of these team members strengthens this foundation.”
Sentrx’s strategic work models and partnerships allows the company to provide professional and qualified service and support to anywhere in the world. In order to expand their scope of business to a widening national and international level and to support recent and future growth, Sentrx also plans to continue hire additional the very best healthcare professionals with specific therapeutic expertise to match customer needs.
Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products during clinical development and post-approval, enabling them to minimize risks and maximize benefits. Through its multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled medical experts, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please visit the company's website at http://www.Sentrx.com, or call 973-812-7575.
150 Clove Road
Phone : 973-812-7575
Tags:technology risk management biotechnology Adverse Events drug safety Drug Safety Solutions Medical Affairs Drug Safety Solutions Provider
Published in:Health & Fitness
Published On:December 5, 2012
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.
Purogenics Announces SoapBerry for Fragrance Allergy Sufferers
National Senior Wii Bowling Day
Boost Male Performance by Reading the Signs Right: Decoding a Partner’s Signals
InnerMovement Chiropractic Moves To A New Home In Downtown Glendale California
New Gym Concept: Hate Gyms But Love Fitness?